Tvardi Therapeutics, Inc. short interest in 2022
In 2022, Tvardi Therapeutics, Inc.'s disclosed short interest ran from 3.26% of shares outstanding on 14 Jan 2022 to 9.23% on 30 Dec 2022, a change of +5.97 percentage points. The year's high was 13.50% on 29 Jul 2022 and its low 3.10% on 31 Jan 2022, averaging 9.86% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 26.85 days on 31 Aug 2022. Full history: Tvardi Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 3.26% (14 Jan 2022)
- End of year
- 9.23% (30 Dec 2022)
- Change
- +5.97 pp
- High
- 13.50% (29 Jul 2022)
- Low
- 3.10% (31 Jan 2022)
- Average
- 9.86%
- Highest days to cover
- 26.85 (31 Aug 2022)
- SEC filings marked
- 9
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 3.26% | 4.75 | results (8-K) |
| 31 Jan 2022 | 3.10% | 3.69 | |
| 15 Feb 2022 | 4.67% | 5.50 | |
| 28 Feb 2022 | 5.86% | 5.79 | |
| 15 Mar 2022 | 7.58% | 5.79 | 10-K filed, results (8-K) |
| 31 Mar 2022 | 7.66% | 9.19 | |
| 14 Apr 2022 | 7.87% | 8.11 | |
| 29 Apr 2022 | 7.70% | 4.97 | |
| 13 May 2022 | 9.98% | 4.82 | 10-Q filed, results (8-K) |
| 31 May 2022 | 11.30% | 10.86 | |
| 15 Jun 2022 | 11.72% | 14.38 | |
| 30 Jun 2022 | 12.12% | 12.05 | |
| 15 Jul 2022 | 13.11% | 18.25 | |
| 29 Jul 2022 | 13.50% | 16.67 | |
| 15 Aug 2022 | 13.36% | 11.09 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 13.27% | 26.85 | |
| 15 Sep 2022 | 13.27% | 23.15 | |
| 30 Sep 2022 | 12.32% | 14.91 | |
| 14 Oct 2022 | 11.87% | 19.96 | |
| 31 Oct 2022 | 11.66% | 20.59 | |
| 15 Nov 2022 | 11.47% | 14.82 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 10.38% | 23.00 | |
| 15 Dec 2022 | 10.35% | 17.87 | |
| 30 Dec 2022 | 9.23% | 10.43 |
See also: Tvardi Therapeutics, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.